Browsing by Author Hochhaus, Andreas
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
|---|---|---|
| 14-Nov-2014 | Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation | García-Albéniz, Xavier; Gallego, Rosa; Hofhteinz, Ralf Dieter; Fernández Esparrach, Glòria; Ayuso Colella, Juan Ramón; Bombí, Josep Antoni; Conill, Carles; Cuatrecasas Freixas, Miriam; Delgado Rivilla, Salvadora; Ginès i Gibert, M. Àngels; Miquel Morera, Rosa; Pagès Llinàs, M. (Mario); Pineda, Estela; Pereira, María Verónica; Sosa, Aarón; Reig Torras, Oscar; Victoria, Iván; Feliz, Luis; Lacy Fortuny, Antonio Ma. de; Castells Garangou, Antoni; Burkholder, Iris; Hochhaus, Andreas; Maurel Santasusana, Joan |
| 10-Jul-2016 | Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial | Cortes, Jorge E.; Saglio, Giuseppe; Kantarjian, Hagop M.; Baccarani, Michele; Mayer, Jiří; Boqué Genovard, Concepción; Shah, Neil P.; Chuah, Charles; Casanova, Luis; Bradley-Garelik, Brigid; Manos, George; Hochhaus, Andreas |
| 9-Mar-2017 | Long-term outcomes of imatinib treatment for chronic myeloid leukemia. | Hochhaus, Andreas; Larson, Richard A.; Guilhot, François; Radich, Jerald P.; Branford, Susan; Hughes, Timothy P.; Baccarani, Michele; Deininger, Michael W.; Cervantes Requena, F.; Fujihara, Satoko; Ortmann, Christine E.; Menssen, Hans D.; Kantarjian, Hagop M.; O'Brien, Stephen G.; Druker, Brian J. |
| 5-Feb-2014 | Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on frontline imatinib or nilotinib 300 mg twice daily. | Hughes, Timothy P.; Hochhaus, Andreas; Kantarjian, Hagop M.; Cervantes Requena, F.; Guilhot, François; Niederwieser, Dietger; le Coutre, Philipp D.; Rosti, Gianantonio; Ossenkoppele, Gert J.; Lobo, Clarisse; Shibayama, Hirohiko; Fan, Xiaolin; Menssen, Hans D.; Kemp, Charisse; Larson, Richard A.; Saglio, Giuseppe |